Dale H. Mugler - Hudson OH, US Yan Wu - Statesboro GA, US
Assignee:
The University of Akron - Akron OH
International Classification:
G06F 11/30 G06F 15/00 G21C 17/00
US Classification:
702182
Abstract:
A system and method for determining a predicted value of a function from at least one previous value of said function and at least one second-derivative value of the function. The system includes a sensor provided to sense a second-derivative value of the function and transmit an oscillatory signal representing the sensed second-derivative value, a computer-readable memory in communication with the sensor to store the previous value of the function and the second-derivative value, and a feature for computing the predicted value of the function using an integration algorithm including a coefficient of integration that is dependant upon at least a frequency of the signal.
Alexander W. Koch - Millbrae CA, US Scott Stawicki - San Francisco CA, US Yan Wu - Foster City CA, US Richard Carano - San Ramon CA, US Ryan J. Watts - San Mateo CA, US
The invention provides anti-Robo4 antibodies, and compositions comprising the antibodies and methods of using these antibodies, including diagnostic and therapeutic methods.
Wei-Ching Liang - Foster City CA, US Gregory D. Plowman - San Carlos CA, US Yan Wu - Foster City CA, US Weilan Ye - Foster City CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
C12P 21/08
US Classification:
5303873, 53038885, 5303911, 5303913, 5303917
Abstract:
The present invention relates to the use of VEGF antagonists and a novel anti-α5β1 antibody for treating cancer and inhibiting angiogenesis and/or vascular permability, including inhibiting abnormal angiogenesis in diseases. The present invention also relates to compositions and kits comprising novel anti-α5β1 antibodies and methods of making and using them.
Wei-Ching Liang - Foster City CA, US Gregory D. Plowman - San Carlos CA, US Yan Wu - Foster City CA, US Weilan Ye - Foster City CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
C07K 16/00 C07K 16/18
US Classification:
5303873, 53038822
Abstract:
The present invention provides new anti-α5β1 antibodies, compositions and kits comprising the antibodies, and methods of making and using the antibodies.
Capital Health Endocrinology Specialists 1235 Whitehorse Mercerville Rd STE 301, Trenton, NJ 08619 (609)8965970 (phone), (609)8965973 (fax)
Education:
Medical School Peking Union Med Coll, Beijing, Beijing, China Graduated: 1987
Conditions:
Disorders of Lipoid Metabolism Anxiety Dissociative and Somatoform Disorders Diabetes Mellitus (DM) Diabetic Peripheral Neuropathy Hypertension (HTN)
Languages:
Chinese English
Description:
Dr. Wu graduated from the Peking Union Med Coll, Beijing, Beijing, China in 1987. She works in Trenton, NJ and specializes in Endocrinology, Diabetes & Metabolism and Diabetes. Dr. Wu is affiliated with Capital Health Medical Center- Hopewell and Capital Health Regional Medical Center.
BlackRock since Jul 2007
Scientific Active Equity
FactSet Research Systems Sep 2005 - Jun 2007
Portfolio Analysis Specialist
Education:
University of California, Berkeley 2001 - 2005
BS, Mechanical Engineering
Skills:
- Quantitative Finance - Investment and Research - Financial Technology - CFA Level II Candidate - Boxing trainer for amateurs MMA fighters physical fitness - Interest in languages (Mandarin Spanish and French) cooking photography traveling
NIST - 100 Bureau Dr. Gaithersburg, MD 20899 since Mar 2012
Research Associate
Motorola Mobility - Beijing, China Nov 2001 - Jul 2002
Software Testing Engineer
Education:
University of Nebraska at Omaha 2005 - 2011
Doctor of Philosophy (Ph.D.), Information Technology
Beijing Institute of Technology 2002 - 2005
Master's degree, Computer Science
Beijing Institute of Technology 1998 - 2002
Bachelor of Science (BSc), Computer Science
Skills:
Data Mining Software Engineering Java C C++ SQL Statistics Agile Methodologies Python